
At SonoThera, we’re advancing genetic medicines diligently to make our technology possible for patients by developing our technology to be: nonviral, noninvasive, safe, effective and accessible, and non-permanent, with the ability to treat the root cause of these diseases for which presently, there are limited or no treatments available.

Our clinical research at SonoThera is foundational to developing the next generation of genetic medicines. We are advancing towards initiating clinical trials and our research is still in preclinical stage. When we will are ready to begin human clinical trials, we will make a public announcement, and the study will be listed on www.clinicaltrials.gov